000			02142 a2200637 4500
005			20250518043137.0
264		0	_c20200622
008			202006s 0 0 eng d
022			_a1474-5488
024	7		_a10.1016/S1470-2045(19)30331-6 _2doi
040			_aNLM _beng _cNLM
100	1		_aLong, Georgina V
245	0	0	_aNeoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF _h[electronic resource]
260			_bThe Lancet. Oncology _c07 2019
300			_a961-971 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImidazoles _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMelanoma _xdrug therapy
650	0	4	_aMiddle Aged
650	0	4	_aMutation
650	0	4	_aNeoadjuvant Therapy
650	0	4	_aNeoplasm Staging
650	0	4	_aOximes _xadministration & dosage
650	0	4	_aProto-Oncogene Proteins B-raf _xgenetics
650	0	4	_aPyridones _xadministration & dosage
650	0	4	_aPyrimidinones _xadministration & dosage
650	0	4	_aSkin Neoplasms _xdrug therapy
700	1		_aSaw, Robyn P M
700	1		_aLo, Serigne
700	1		_aNieweg, Omgo E
700	1		_aShannon, Kerwin F
700	1		_aGonzalez, Maria
700	1		_aGuminski, Alexander
700	1		_aLee, Jenny H
700	1		_aLee, Hansol
700	1		_aFerguson, Peter M
700	1		_aRawson, Robert V
700	1		_aWilmott, James S
700	1		_aThompson, John F
700	1		_aKefford, Richard F
700	1		_aCh'ng, Sydney
700	1		_aStretch, Jonathan R
700	1		_aEmmett, Louise
700	1		_aKapoor, Rony
700	1		_aRizos, Helen
700	1		_aSpillane, Andrew J
700	1		_aScolyer, Richard A
700	1		_aMenzies, Alexander M
773	0		_tThe Lancet. Oncology _gvol. 20 _gno. 7 _gp. 961-971
856	4	0	_uhttps://doi.org/10.1016/S1470-2045(19)30331-6 _zAvailable from publisher's website
999			_c29771320 _d29771320